journal article·2023-12

Glucose-responsive enzymatic biomimetic nanodots for H2O2 self-supplied catalytic photothermal/chemodynamic anticancer therapy

Yinghui Xu, Jiayi Bian, Xin Liu, Zhengzheng Qian, Minghao Sun, Cheng Zhang, Ruiyang Pan, Qitong Li, Changrui Sun, Bin Lin, Kun Peng, Nan Lu, Xikuang Yao, Wenpei Fan

Acta Biomaterialia· Volume 172
Publisher page

Abstract

Photothermal therapy (PTT) combined with chemodynamic therapy (CDT) presents an appealing complementary anti-tumor strategy, wherein PTT accelerates the production of reactive oxygen species (ROS) in CDT and CDT eliminates residual tumor tissues that survive from PTT treatment. However, nanomaterials utilized in PTT/CDT are limited by non-specific damage to the entire organism. Herein, a glucose-responsive enzymatic Fe@HRP-ABTS/GOx nanodot is judiciously designed for tumor-specific PTT/CDT via a simple and clean protein-templated biomimetic mineralization synthesis. By oxidizing glucose in tumor cells, glucose oxidase (GOx) activates glucose-responsive tumor therapy and increases the concentration of H2O2 at the tumor site. More importantly, the self-supplied peroxide hydrogen (H2O2) can convert ABTS (2,2'-Hydrazine-bis(3-ethylbenzothiazoline-6-sulfonic acid) diamine salt) into oxidized ABTS (oxABTS) through horseradish peroxidase (HRP) catalysis for PTT and photoacoustic (PA) imaging. Furthermore, the Fe2+ arising from the reduction of Fe3+ by overexpressed GSH reacts with H2O2 to generate intensely reactive •OH through the Fenton reaction, concurrently depleting GSH and inducing efficient tumor CDT. The in vitro and in vivo experiments demonstrate superior cancer cell killing and tumor eradication effect of Fe@HRP-ABTS/GOx nanodot under near-infrared (NIR) laser irradiation. Collectively, the nanodots provide mutually reinforcing catalytic PTT/CDT anti-tumor strategies for treating liver cancer and potentially other malignancies. STATEMENT OF SIGNIFICANCE: Combinatorial antitumor therapy with nanomedicines presents great prospects for development. However, the limitation of non-specific damage to normal tissues hinders its further clinical application. In this work, we fabricated tumor-selective biomimetic Fe@HRP-ABTS/GOx nanodots for H2O2 self-supplied catalytic photothermal/chemodynamic therapy of tumors. The biomimetic synthesis strategy provides the nanodots with enzymatic activity in response to glucose to produce H2O2. The self-supplied H2O2 initiates photothermal therapy with oxidized ABTS and enhances chemodynamic therapy through simultaneous •OH generation and GSH depletion. Our work provides a new paradigm for developing tumor-selective catalytic nanomedicines and will guide further clinical translation of the enzymatic biomimetic synthesis strategy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Highly efficient 2d NIR-II photothermal agent with Fenton catalytic activity for cancer synergistic photothermal–chemodynamic therapy
2. Organic molecule-based photothermal agents: an expanding photothermal therapy universe10.1039/C7CS00522A ↗
3. Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars10.1038/s41565-022-01189-y ↗
4. Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts10.1038/s41467-022-30306-7 ↗
5. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer10.1039/C8CS00618K ↗
6. Boosting chemodynamic therapy by tumor-targeting and cellular redox homeostasis-disrupting nanoparticles10.1021/acsami.2c11091 ↗
7. Tumor microenvironment-activated theranostics nanozymes for fluorescence imaging and enhanced chemo-chemodynamic therapy of tumors10.1021/acsami.1c12611 ↗
8. Chemodynamic therapy: Tumour microenvironment-mediated Fenton and Fenton-like reactions10.1002/anie.201805664 ↗
9. Metal-phenolic-network-coated dendrimer-drug conjugates for tumor MR imaging and chemo/chemodynamic therapy via amplification of endoplasmic reticulum stress
10. All-in-one theranostic nanomedicine with ultrabright second near-infrared emission for tumor-modulated bioimaging and chemodynamic/photodynamic therapy10.1021/acsnano.0c00082 ↗
11. Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy
12. Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry10.1039/D1SC05482A ↗
13. Enhanced chemodynamic and photoluminescence efficiencies of Fe–O4 coordinated carbon dots via the core–shell synergistic effect10.1039/D2NR05281D ↗
14. Simultaneous Fenton-like ion delivery and glutathione depletion by mno(2) -based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
15. Supramolecular polymerization-induced nanoassemblies for self-augmented cascade chemotherapy and chemodynamic therapy of tumor10.1002/anie.202103721 ↗
16. Injectable hydrogel for postoperative synergistic photothermal-chemodynamic tumor and anti-infection therapy10.1016/j.biomaterials.2021.121289 ↗
17. Osteogenic and anti-tumor cu and mn-doped borosilicate nanoparticles for syncretic bone repair and chemodynamic therapy in bone tumor treatment
18. Molybdenum diphosphide nanorods with laser-potentiated peroxidase catalytic/mild-photothermal therapy of oral cancer
19. An organic nanotherapeutic agent self-assembled from cyanine and cu (II) for combined photothermal and chemodynamic therapy10.1002/adhm.202101008 ↗
20. Programmable NIR-II photothermal-enhanced starvation-primed chemodynamic therapy using glucose oxidase-functionalized ancient pigment nanosheets10.1002/smll.202001518 ↗
21. Mo(2) c-derived polyoxometalate for NIR-II photoacoustic imaging-guided chemodynamic/photothermal synergistic therapy10.1002/anie.201910815 ↗
22. Nanoparticle uptake: the phagocyte problem10.1016/j.nantod.2015.06.006 ↗
23. Effects of engineered nanoparticles on the innate immune system10.1016/j.smim.2017.09.011 ↗
24. Tumor microenvironment-activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade10.1002/adma.201805888 ↗
25. Redox-activatable and acid-enhanced nanotheranostics for second near-infrared photoacoustic tomography and combined photothermal tumor therapy10.1021/acsnano.9b01411 ↗
26. Semiconducting polymer nano-protacs for activatable photo-immunometabolic cancer therapy10.1038/s41467-021-23194-w ↗
27. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific cu-chelate chemotherapy and cascaded photodynamic therapy10.1016/j.biomaterials.2022.121513 ↗
28. Holographically activatable nanoprobe via glutathione/albumin-mediated exponential signal amplification for high-contrast tumor imaging
29. Engineering of electrochromic materials as activatable probes for molecular imaging and photodynamic therapy10.1021/jacs.8b10176 ↗
30. Erythrocyte membrane cloaked metal–organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy10.1021/acsnano.8b05200 ↗
31. Cancer metabolism: A therapeutic perspective10.1038/nrclinonc.2016.60 ↗
32. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes10.1126/science.1193494 ↗
33. Tumor-activatable biomineralized nanotherapeutics for integrative glucose starvation and sensitized metformin therapy10.1016/j.biomaterials.2021.121165 ↗
34. Metabolic competition in the tumor microenvironment is a driver of cancer progression10.1016/j.cell.2015.08.016 ↗
35. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment10.1039/C7CS00891K ↗
36. Enzyme-laden bioactive hydrogel for biocatalytic monitoring and regulation10.1021/acs.accounts.0c00832 ↗
37. Glucose oxidase-amplified CO generation for synergistic anticancer therapy via manganese carbonyl-caged MOFs10.1016/j.actbio.2022.10.018 ↗
38. Bioorthogonal catalysis for treatment of solid tumors using thermostable, self-assembling, single enzyme nanoparticles and natural product conversion with indole-3-acetic acid10.1021/acsnano.1c11560 ↗
39. New glucose oxidase-immobilized stimuli-responsive dextran nanoparticles for insulin delivery10.1016/j.ijbiomac.2018.11.147 ↗
40. Enzyme-engineered conjugated polymer nanoplatform for activatable companion diagnostics and multistage augmented synergistic therapy
41. Biomimetic mineralization based on self-assembling peptides10.1039/D2CS00725H ↗
42. Glucose oxidase—an overview10.1016/j.biotechadv.2009.04.003 ↗
43. Glucose oxidase-instructed traceable self-oxygenation/hyperthermia dually enhanced cancer starvation therapy10.7150/thno.40439 ↗
44. Nanoclustered cascaded enzymes for targeted tumor starvation and deoxygenation-activated chemotherapy without systemic toxicity10.1021/acsnano.9b02466 ↗
45. Peroxidase-immobilized porous silica particles for in situ formation of peroxidase-free hydrogels with attenuated immune responses10.1016/j.actbio.2018.09.054 ↗
46. Enzymatic bionanocatalysts for combating peri-implant biofilm infections by specific heat-amplified chemodynamic therapy and innate immunomodulation10.1016/j.drup.2022.100917 ↗
47. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator10.1016/j.biomaterials.2020.119911 ↗
48. A polydopamine coated nanoscale fes theranostic platform for the elimination of drug-resistant bacteria via photothermal-enhanced Fenton reaction10.1016/j.actbio.2022.07.046 ↗
49. An effective Fenton reaction by using waste ferric iron and red phosphorus10.1016/j.cej.2022.135265 ↗
50. Biomedicine meets Fenton chemistry10.1021/acs.chemrev.0c00977 ↗
51. An engineered protein-Au bioplaster for efficient skin tumor therapy10.1002/adma.202110062 ↗
52. Injectable in situ forming hydrogels of thermosensitive polypyrrole nanoplatforms for precisely synergistic photothermo-chemotherapy10.1021/acsami.9b22654 ↗